SPDR S&P BIOTECH ETF (XBI)
NYSEARCA: XBI · Real-Time Price · USD
84.40
-1.13 (-1.32%)
At close: Mar 28, 2025, 4:00 PM
84.10
-0.30 (-0.36%)
After-hours: Mar 28, 2025, 7:59 PM EDT
XBI Holdings List
As of Mar 27, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.74% |
2 | INSM | Insmed Incorporated | 2.58% |
3 | NBIX | Neurocrine Biosciences, Inc. | 2.57% |
4 | NTRA | Natera, Inc. | 2.52% |
5 | VRTX | Vertex Pharmaceuticals Incorporated | 2.49% |
6 | UTHR | United Therapeutics Corporation | 2.46% |
7 | BIIB | Biogen Inc. | 2.46% |
8 | AMGN | Amgen Inc. | 2.40% |
9 | GILD | Gilead Sciences, Inc. | 2.39% |
10 | EXAS | Exact Sciences Corporation | 2.38% |
11 | ABBV | AbbVie Inc. | 2.35% |
12 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.29% |
13 | REGN | Regeneron Pharmaceuticals, Inc. | 2.26% |
14 | MRNA | Moderna, Inc. | 2.25% |
15 | INCY | Incyte Corporation | 2.20% |
16 | BMRN | BioMarin Pharmaceutical Inc. | 2.17% |
17 | PCVX | Vaxcyte, Inc. | 2.12% |
18 | BPMC | Blueprint Medicines Corporation | 2.02% |
19 | EXEL | Exelixis, Inc. | 1.93% |
20 | BBIO | BridgeBio Pharma, Inc. | 1.67% |
21 | TGTX | TG Therapeutics, Inc. | 1.66% |
22 | HALO | Halozyme Therapeutics, Inc. | 1.63% |
23 | SRPT | Sarepta Therapeutics, Inc. | 1.59% |
24 | CYTK | Cytokinetics, Incorporated | 1.44% |
25 | RVMD | Revolution Medicines, Inc. | 1.41% |
26 | IONS | Ionis Pharmaceuticals, Inc. | 1.27% |
27 | CRSP | CRISPR Therapeutics AG | 1.26% |
28 | SWTX | SpringWorks Therapeutics, Inc. | 1.20% |
29 | ROIV | Roivant Sciences Ltd. | 1.18% |
30 | ALKS | Alkermes plc | 1.15% |
31 | VKTX | Viking Therapeutics, Inc. | 1.09% |
32 | SMMT | Summit Therapeutics Inc. | 1.07% |
33 | RNA | Avidity Biosciences, Inc. | 1.07% |
34 | ADMA | ADMA Biologics, Inc. | 1.03% |
35 | KRYS | Krystal Biotech, Inc. | 1.00% |
36 | APLS | Apellis Pharmaceuticals, Inc. | 0.99% |
37 | TWST | Twist Bioscience Corporation | 0.94% |
38 | ACLX | Arcellx, Inc. | 0.91% |
39 | NUVL | Nuvalent, Inc. | 0.86% |
40 | SRRK | Scholar Rock Holding Corporation | 0.85% |
41 | RXRX | Recursion Pharmaceuticals, Inc. | 0.81% |
42 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.81% |
43 | RARE | Ultragenyx Pharmaceutical Inc. | 0.78% |
44 | VCYT | Veracyte, Inc. | 0.78% |
45 | ACAD | ACADIA Pharmaceuticals Inc. | 0.78% |
46 | BHVN | Biohaven Ltd. | 0.77% |
47 | AKRO | Akero Therapeutics, Inc. | 0.73% |
48 | PTCT | PTC Therapeutics, Inc. | 0.71% |
49 | SLNO | Soleno Therapeutics, Inc. | 0.71% |
50 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.70% |
51 | TVTX | Travere Therapeutics, Inc. | 0.67% |
52 | AGIO | Agios Pharmaceuticals, Inc. | 0.66% |
53 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.60% |
54 | BEAM | Beam Therapeutics Inc. | 0.60% |
55 | IMVT | Immunovant, Inc. | 0.59% |
56 | CPRX | Catalyst Pharmaceuticals, Inc. | 0.59% |
57 | ARQT | Arcutis Biotherapeutics, Inc. | 0.59% |
58 | MIRM | Mirum Pharmaceuticals, Inc. | 0.54% |
59 | SNDX | Syndax Pharmaceuticals, Inc. | 0.53% |
60 | DVAX | Dynavax Technologies Corporation | 0.51% |
61 | VERA | Vera Therapeutics, Inc. | 0.51% |
62 | VCEL | Vericel Corporation | 0.50% |
63 | PTGX | Protagonist Therapeutics, Inc. | 0.50% |
64 | FOLD | Amicus Therapeutics, Inc. | 0.49% |
65 | CLDX | Celldex Therapeutics, Inc. | 0.49% |
66 | IDYA | IDEAYA Biosciences, Inc. | 0.48% |
67 | ARDX | Ardelyx, Inc. | 0.46% |
68 | NVAX | Novavax, Inc. | 0.46% |
69 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.45% |
70 | CGON | CG Oncology, Inc. | 0.44% |
71 | DNLI | Denali Therapeutics Inc. | 0.42% |
72 | CDNA | CareDx, Inc | 0.41% |
73 | IRON | Disc Medicine, Inc. | 0.41% |
74 | KYMR | Kymera Therapeutics, Inc. | 0.40% |
75 | GRAL | GRAIL, Inc. | 0.40% |
76 | DYN | Dyne Therapeutics, Inc. | 0.39% |
77 | APGE | Apogee Therapeutics, Inc. | 0.38% |
78 | JANX | Janux Therapeutics, Inc. | 0.38% |
79 | VRDN | Viridian Therapeutics, Inc. | 0.35% |
80 | IOVA | Iovance Biotherapeutics, Inc. | 0.35% |
81 | NTLA | Intellia Therapeutics, Inc. | 0.34% |
82 | GERN | Geron Corporation | 0.33% |
83 | NRIX | Nurix Therapeutics, Inc. | 0.31% |
84 | MYGN | Myriad Genetics, Inc. | 0.31% |
85 | MNKD | MannKind Corporation | 0.31% |
86 | SYRE | Spyre Therapeutics, Inc. | 0.28% |
87 | ETNB | 89bio, Inc. | 0.28% |
88 | RCKT | Rocket Pharmaceuticals, Inc. | 0.28% |
89 | AVXL | Anavex Life Sciences Corp. | 0.28% |
90 | VIR | Vir Biotechnology, Inc. | 0.26% |
91 | PRAX | Praxis Precision Medicines, Inc. | 0.26% |
92 | COGT | Cogent Biosciences, Inc. | 0.25% |
93 | IBRX | ImmunityBio, Inc. | 0.25% |
94 | QURE | uniQure N.V. | 0.25% |
95 | XNCR | Xencor, Inc. | 0.23% |
96 | CAPR | Capricor Therapeutics, Inc. | 0.22% |
97 | DAWN | Day One Biopharmaceuticals, Inc. | 0.22% |
98 | RCUS | Arcus Biosciences, Inc. | 0.22% |
99 | SPRY | ARS Pharmaceuticals, Inc. | 0.22% |
100 | KURA | Kura Oncology, Inc. | 0.21% |
101 | REPL | Replimune Group, Inc. | 0.19% |
102 | ALT | Altimmune, Inc. | 0.18% |
103 | IMNM | Immunome, Inc. | 0.17% |
104 | RLAY | Relay Therapeutics, Inc. | 0.14% |
105 | KROS | Keros Therapeutics, Inc. | 0.14% |
106 | VERV | Verve Therapeutics, Inc. | 0.13% |
107 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.13% |
108 | ANAB | AnaptysBio, Inc. | 0.13% |
109 | PRTA | Prothena Corporation plc | 0.13% |
110 | EBS | Emergent BioSolutions Inc. | 0.12% |
111 | MDXG | MiMedx Group, Inc. | 0.12% |
112 | ORIC | ORIC Pharmaceuticals, Inc. | 0.11% |
113 | DNTH | Dianthus Therapeutics, Inc. | 0.11% |
114 | STOK | Stoke Therapeutics, Inc. | 0.10% |
115 | CGEM | Cullinan Therapeutics, Inc. | 0.10% |
116 | AKBA | Akebia Therapeutics, Inc. | 0.09% |
117 | RIGL | Rigel Pharmaceuticals, Inc. | 0.09% |
118 | HUMA | Humacyte, Inc. | 0.08% |
119 | SANA | Sana Biotechnology, Inc. | 0.08% |
120 | KALV | KalVista Pharmaceuticals, Inc. | 0.07% |
121 | AVBP | ArriVent BioPharma, Inc. | 0.07% |
122 | ABUS | Arbutus Biopharma Corporation | 0.06% |
123 | - | SSI US GOV MONEY MARKET CLASS | 0.06% |
124 | ORGO | Organogenesis Holdings Inc. | 0.03% |
125 | SCLX | Scilex Holding Company | 0.03% |
126 | - | US DOLLAR | 0.02% |
127 | - | CONTRA INHIBRX INC | 0.02% |
128 | - | CONTRA MIRATI THERAPEU | 0.02% |
129 | 2200963D | OMNIAB INC 12.5 EARNOUT | 0.00% |
130 | 2200964D | OMNIAB INC 15.00 EARNOUT | 0.00% |
As of Mar 27, 2025